Exam 2 PPT Slides - Supply Chain

Descripción

Exam 2 PPT Slides - Supply Chain
Kevin Vu
Test por Kevin Vu, actualizado hace más de 1 año
Kevin Vu
Creado por Kevin Vu hace alrededor de 9 años
41
0

Resumen del Recurso

Pregunta 1

Pregunta
Drug: “Substances that produce a change in cellular or physiological functioning of humans.”
Respuesta
  • True
  • False

Pregunta 2

Pregunta
For Drugs... End-point of the supply chain drives demand
Respuesta
  • True
  • False

Pregunta 3

Pregunta
The five factors influencing prescribing behavior are:
Respuesta
  • Education
  • Colleagues or other health care providers
  • Control and regulatory mechanisms
  • Demands by consumers and society
  • Promotional activities by drug manufacturers
  • Kickbacks from pharmaceutical companies

Pregunta 4

Pregunta
What are the two main acts used by the FDA to control pharmaceuticals?
Respuesta
  • Food, Drug, and Cosmetic Act
  • Public Health Service Act
  • HIPPA Act
  • Omnibus Act

Pregunta 5

Pregunta
Non-FDA-approved (“off-label”) indications are uses of a product that were not approved by the FDA, but have shown value after approval based on postmarketing research.
Respuesta
  • True
  • False

Pregunta 6

Pregunta
Non-FDA-approved indications can be promoted by the manufacturer.
Respuesta
  • True
  • False

Pregunta 7

Pregunta
The FDA started allowing direct advertising in what year?
Respuesta
  • 1985
  • 1991
  • 1995
  • 1997

Pregunta 8

Pregunta
Drug prices: Suggested price determined by manufacturer is usually a different price (much lower) that is actually paid out-of-pocket by most consumers based on their insurance plan.
Respuesta
  • True
  • False

Pregunta 9

Pregunta
This phase in the drug development is tested on non-human subject
Respuesta
  • Phase 0
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

Pregunta 10

Pregunta
Which of the phases allow human trail?
Respuesta
  • Phase 0
  • Phase 1
  • Phase 2
  • Phase 3

Pregunta 11

Pregunta
Phase 1 trials allow 20-80 people (for safety, dosing range, and side effects). Phase 2 trials allow 100-300 people (for effective and further evaluation of safety). Phase 3 trials allow how many people (to confirm effectiveness, monitor side effects, and compared it to commonly used treatments)?
Respuesta
  • 500-1000
  • 1000-3000
  • 4000-5000

Pregunta 12

Pregunta
Phase 4 trial - post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
Respuesta
  • True
  • False
Mostrar resumen completo Ocultar resumen completo

Similar

Exam 1 Medications
tera_alise
pharmacology chapter 8 and 20
Alannah Mendoza
module 4 chapter 19
Alannah Mendoza
module 5 pharmacology chapter 9
Alannah Mendoza
Module 6 Chapters 12/14
Alannah Mendoza
Neuro anatomy
James Murdoch
Respiratory anatomy
James Murdoch
PHARMACOLOGY BLOCK 1- basic intro
wallacejr@hotmail.co
PUBLIC HEALTH
Zinab Keshk
First Aid
Reuben Caruana